Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Perazzolo

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|June 27, 2025
Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic EnhancementSimone Perazzolo, Charles W Flexner, Zachary R Stephen, et al.
Journal of Pharmaceutical Sciences|August 20, 2018
Three HIV Drugs, Atazanavir, Ritonavir, and Tenofovir, Coformulated in Drug-Combination Nanoparticles Exhibit Long-Acting and Lymphocyte-Targeting Properties in Nonhuman PrimatesSimone Perazzolo, Laura M Shireman, Josefin Koehn, et al.
Pharmaceutical Research|September 24, 2020
Novel Long-Acting Drug Combination Nanoparticles Composed of Gemcitabine and Paclitaxel Enhance Localization of Both Drugs in Metastatic Breast Cancer NodulesJesse Yu, Qingxin Mu, Simone Perazzolo, et al.
AIDS (London, England)|August 31, 2023
A novel formulation enabled transformation of 3-HIV drugs tenofovir-lamivudine-dolutegravir from short-acting to long-acting all-in-one injectableSimone Perazzolo, Zachary R Stephen, Masa Eguchi, et al.
Annual Review of Pharmacology and Toxicology|September 16, 2025
The Promises and Prospects of Long-Acting Therapeutics for Treatment and Prevention of Infectious DiseasesAdeniyi Olagunju, Simone Perazzolo, Zachary R Stephen, et al.
Journal of Pharmaceutical Sciences|February 2, 2020
Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First-Pass Lymphatic Drug Sequestration and Long-Acting Pharmacokinetics of the Injectable Triple-HIV Drug Combination TLC-ART 101Simone Perazzolo, Laura M Shireman, Lisa A McConnachie, et al.
Frontiers in Immunology|October 4, 2023
Viral dissemination and immune activation modulate antiretroviral drug levels in lymph nodes of SIV-infected rhesus macaquesSharat Srinivasula, Paula Degrange, Simone Perazzolo, et al.
Diabetologia|August 14, 2024
Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetesKieran Smith, Guy S Taylor, Wouter Peeters, et al.
AIDS (London, England)|May 5, 2026
A novel all-in-one injectable composed of tenofovir alafenamide-dolutegravir-lamivudine exhibits long-acting plasma and cell drug persistence for 8 weeksZachary R Stephen, Simone Perazzolo, Luqi Duan, et al.
The Journal of Physiology|July 10, 2019
In vivo kinetic study of materno-fetal fatty acid transfer in obese and normal weight pregnant womenAntonio Gázquez, María T Prieto-Sánchez, José E Blanco-Carnero, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|June 27, 2025
Long-acting Injectable Containing Lopinavir Eliminates Reliance on Ritonavir Pharmacokinetic EnhancementSimone Perazzolo, Charles W Flexner, Zachary R Stephen, et al.
Journal of Pharmaceutical Sciences|August 20, 2018
Three HIV Drugs, Atazanavir, Ritonavir, and Tenofovir, Coformulated in Drug-Combination Nanoparticles Exhibit Long-Acting and Lymphocyte-Targeting Properties in Nonhuman PrimatesSimone Perazzolo, Laura M Shireman, Josefin Koehn, et al.
Pharmaceutical Research|September 24, 2020
Novel Long-Acting Drug Combination Nanoparticles Composed of Gemcitabine and Paclitaxel Enhance Localization of Both Drugs in Metastatic Breast Cancer NodulesJesse Yu, Qingxin Mu, Simone Perazzolo, et al.
AIDS (London, England)|August 31, 2023
A novel formulation enabled transformation of 3-HIV drugs tenofovir-lamivudine-dolutegravir from short-acting to long-acting all-in-one injectableSimone Perazzolo, Zachary R Stephen, Masa Eguchi, et al.
Annual Review of Pharmacology and Toxicology|September 16, 2025
The Promises and Prospects of Long-Acting Therapeutics for Treatment and Prevention of Infectious DiseasesAdeniyi Olagunju, Simone Perazzolo, Zachary R Stephen, et al.
Journal of Pharmaceutical Sciences|February 2, 2020
Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First-Pass Lymphatic Drug Sequestration and Long-Acting Pharmacokinetics of the Injectable Triple-HIV Drug Combination TLC-ART 101Simone Perazzolo, Laura M Shireman, Lisa A McConnachie, et al.
Frontiers in Immunology|October 4, 2023
Viral dissemination and immune activation modulate antiretroviral drug levels in lymph nodes of SIV-infected rhesus macaquesSharat Srinivasula, Paula Degrange, Simone Perazzolo, et al.
Diabetologia|August 14, 2024
Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetesKieran Smith, Guy S Taylor, Wouter Peeters, et al.
AIDS (London, England)|May 5, 2026
A novel all-in-one injectable composed of tenofovir alafenamide-dolutegravir-lamivudine exhibits long-acting plasma and cell drug persistence for 8 weeksZachary R Stephen, Simone Perazzolo, Luqi Duan, et al.
The Journal of Physiology|July 10, 2019
In vivo kinetic study of materno-fetal fatty acid transfer in obese and normal weight pregnant womenAntonio Gázquez, María T Prieto-Sánchez, José E Blanco-Carnero, et al.
Pageof 3